-
1
-
-
0036896722
-
Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer
-
Kaanders JH, Wijffels KI, Marres HA, et al. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res 2002; 62: 7066-74.
-
(2002)
Cancer Res
, vol.62
, pp. 7066-7074
-
-
Kaanders, J.H.1
Wijffels, K.I.2
Marres, H.A.3
-
2
-
-
2942590732
-
Exploiting tumour hypoxia in cancer treatment
-
Brown JM, Wilson WR. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 2004; 4: 437-47.
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 437-447
-
-
Brown, J.M.1
Wilson, W.R.2
-
4
-
-
0037267568
-
Modulation of cell death in the tumor microenvironment
-
Wouters BG, Koritzinsky M, Chiu RK, Theys J, Buijsen J, Lambin P. Modulation of cell death in the tumor microenvironment. Semin Radiat Oncol 2003; 13: 31-41.
-
(2003)
Semin Radiat Oncol
, vol.13
, pp. 31-41
-
-
Wouters, B.G.1
Koritzinsky, M.2
Chiu, R.K.3
Theys, J.4
Buijsen, J.5
Lambin, P.6
-
5
-
-
0038242819
-
TRB3: A tribbles homolog that inhibits Akt/PKB activation by insulin in liver
-
Du KY, Herzig S, Kulkarni RN, Montminy M. TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 2003; 300: 1574-7.
-
(2003)
Science
, vol.300
, pp. 1574-1577
-
-
Du, K.Y.1
Herzig, S.2
Kulkarni, R.N.3
Montminy, M.4
-
6
-
-
5644285309
-
Human tribbles, a protein family controlling mitogen-activated protein kinase cascades
-
Kiss-Toth E, Bagstaff SM, Sung HY, et al. Human tribbles, a protein family controlling mitogen-activated protein kinase cascades. J Biol Chem 2004; 279: 42703-8.
-
(2004)
J Biol Chem
, vol.279
, pp. 42703-42708
-
-
Kiss-Toth, E.1
Bagstaff, S.M.2
Sung, H.Y.3
-
7
-
-
48649103713
-
Multiple pathways are involved in the anoxia response of SKIP3 including HuR-regulated RNA stability, NF-kappaB and ATF4
-
Rzymski T, Paantjens A, Bod J, Harris AL. Multiple pathways are involved in the anoxia response of SKIP3 including HuR-regulated RNA stability, NF-kappaB and ATF4. Oncogene 2008; 27: 4532-43.
-
(2008)
Oncogene
, vol.27
, pp. 4532-4543
-
-
Rzymski, T.1
Paantjens, A.2
Bod, J.3
Harris, A.L.4
-
8
-
-
79956220948
-
Tribbles in disease: Signaling pathways important for cellular function and neoplastic transformation
-
Yokoyama T, Nakamura T. Tribbles in disease: Signaling pathways important for cellular function and neoplastic transformation. Cancer Sci 2011; 102: 1115-22.
-
(2011)
Cancer Sci
, vol.102
, pp. 1115-1122
-
-
Yokoyama, T.1
Nakamura, T.2
-
9
-
-
80052025916
-
Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response
-
Wennemers M, Bussink J, Scheijen B, et al. Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response. Breast Cancer Res 2011; 13: R82.
-
(2011)
Breast Cancer Res
, vol.13
-
-
Wennemers, M.1
Bussink, J.2
Scheijen, B.3
-
10
-
-
34548357145
-
Velopharyngeal sequels in labial-alveolar-velopalatine clefts. Veloplasty and pharyngoplasty using an inferior or superior pedicle pharyngeal flap
-
Vazquez MP, Soupre V, Benateau H, et al. Velopharyngeal sequels in labial-alveolar-velopalatine clefts. Veloplasty and pharyngoplasty using an inferior or superior pedicle pharyngeal flap. Rev Stomatol Chir Maxillofac 2007; 108: 334-42.
-
(2007)
Rev Stomatol Chir Maxillofac
, vol.108
, pp. 334-342
-
-
Vazquez, M.P.1
Soupre, V.2
Benateau, H.3
-
11
-
-
74949118681
-
The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5
-
Rouschop KM, van den Beucken T, Dubois L, et al. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J Clin Invest 2010; 120: 127-41.
-
(2010)
J Clin Invest
, vol.120
, pp. 127-141
-
-
Rouschop, K.M.1
van den Beucken, T.2
Dubois, L.3
-
12
-
-
68349135032
-
Regulation of autophagy through multiple independent hypoxic signaling pathways
-
Rouschop KM, Wouters BG. Regulation of autophagy through multiple independent hypoxic signaling pathways. Curr Mol Med 2009; 9: 417-24.
-
(2009)
Curr Mol Med
, vol.9
, pp. 417-424
-
-
Rouschop, K.M.1
Wouters, B.G.2
-
13
-
-
80655124688
-
TRIB3 protein denotes a good prognosis in breast cancer patients and is associated with hypoxia sensitivity
-
Wennemers M, Bussink J, Grebenchtchikov N, Sweep FC, Span PN. TRIB3 protein denotes a good prognosis in breast cancer patients and is associated with hypoxia sensitivity. Radiother Oncol 2011; 101: 198-202.
-
(2011)
Radiother Oncol
, vol.101
, pp. 198-202
-
-
Wennemers, M.1
Bussink, J.2
Grebenchtchikov, N.3
Sweep, F.C.4
Span, P.N.5
-
15
-
-
0029150035
-
Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts
-
Rijken PF, Bernsen HJ, van der Kogel AJ. Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts. Microvasc Res 1995; 50: 141-53.
-
(1995)
Microvasc Res
, vol.50
, pp. 141-153
-
-
Rijken, P.F.1
Bernsen, H.J.2
van der Kogel, A.J.3
-
16
-
-
79960906420
-
Parametric mapping of immunohistochemically stained tissue sections; a method to quantify the colocalization of tumor markers
-
Rademakers SE, Rijken PF, Peeters WJ, et al. Parametric mapping of immunohistochemically stained tissue sections; a method to quantify the colocalization of tumor markers. Cell Oncol 2009; 34: 119-29.
-
(2009)
Cell Oncol
, vol.34
, pp. 119-129
-
-
Rademakers, S.E.1
Rijken, P.F.2
Peeters, W.J.3
-
17
-
-
23844534811
-
Reporting recommendations for tumor marker prognostic studies (REMARK)
-
Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics
-
McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics. Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 2005; 97: 1180-4.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 1180-1184
-
-
McShane, L.M.1
Altman, D.G.2
Sauerbrei, W.3
Taube, S.E.4
Gion, M.5
Clark, G.M.6
-
18
-
-
33744948425
-
Hypoxia regulates cross-talk between Syk and Lck leading to breast cancer progression and angiogenesis
-
Chakraborty G, Rangaswami H, Jain S, Kundu GC. Hypoxia regulates cross-talk between Syk and Lck leading to breast cancer progression and angiogenesis. J Biol Chem 2006; 281: 11322-31.
-
(2006)
J Biol Chem
, vol.281
, pp. 11322-11331
-
-
Chakraborty, G.1
Rangaswami, H.2
Jain, S.3
Kundu, G.C.4
-
19
-
-
80053208251
-
PI3K and ERK-induced Rac1 activation mediates hypoxia-induced HIF-1alpha expression in MCF-7 breast cancer cells
-
Du J, Xu R, Hu Z, et al. PI3K and ERK-induced Rac1 activation mediates hypoxia-induced HIF-1alpha expression in MCF-7 breast cancer cells. PLoS One 2011; 6: e25213.
-
(2011)
PLoS One
, vol.6
-
-
Du, J.1
Xu, R.2
Hu, Z.3
-
20
-
-
0035000258
-
Hypoxia-induced upregulation of eNOS gene expression is redox-sensitive: A comparison between hypoxia and inhibitors of cell metabolism
-
Hoffmann A, Gloe T, Pohl U. Hypoxia-induced upregulation of eNOS gene expression is redox-sensitive: a comparison between hypoxia and inhibitors of cell metabolism. J Cell Physiol 2001; 188: 33-44.
-
(2001)
J Cell Physiol
, vol.188
, pp. 33-44
-
-
Hoffmann, A.1
Gloe, T.2
Pohl, U.3
-
21
-
-
0344873719
-
Hypoxia activates signal transducers and activators of transcription 5 (STAT5) and increases its binding activity to the GAS element in mammary epithelial cells
-
Joung YH, Park JH, Park T, et al. Hypoxia activates signal transducers and activators of transcription 5 (STAT5) and increases its binding activity to the GAS element in mammary epithelial cells. Exp Mol Med 2003; 35: 350-7.
-
(2003)
Exp Mol Med
, vol.35
, pp. 350-357
-
-
Joung, Y.H.1
Park, J.H.2
Park, T.3
-
22
-
-
33748550248
-
Hypoxia confers protection against apoptosis via PI3K/Akt and ERK pathways in lung cancer cells
-
Lee SM, Lee CT, Kim YW, Han SK, Shim YS, Yoo CG. Hypoxia confers protection against apoptosis via PI3K/Akt and ERK pathways in lung cancer cells. Cancer Lett 2006; 242: 231-8.
-
(2006)
Cancer Lett
, vol.242
, pp. 231-238
-
-
Lee, S.M.1
Lee, C.T.2
Kim, Y.W.3
Han, S.K.4
Shim, Y.S.5
Yoo, C.G.6
-
23
-
-
0027938194
-
Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms
-
McQuillan LP, Leung GK, Marsden PA, Kostyk SK, Kourembanas S. Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. Am J Physiol 1994; 267: H1921-7.
-
(1994)
Am J Physiol
, vol.267
-
-
McQuillan, L.P.1
Leung, G.K.2
Marsden, P.A.3
Kostyk, S.K.4
Kourembanas, S.5
-
24
-
-
80053990934
-
TRB3 overexpression due to endoplasmic reticulum stress inhibits AKT kinase activation of tongue squamous cell carcinoma
-
Zhang J, Wen HJ, Guo ZM, et al. TRB3 overexpression due to endoplasmic reticulum stress inhibits AKT kinase activation of tongue squamous cell carcinoma. Oral Oncol 2011; 47: 934-9.
-
(2011)
Oral Oncol
, vol.47
, pp. 934-939
-
-
Zhang, J.1
Wen, H.J.2
Guo, Z.M.3
-
25
-
-
14244265623
-
Lack of evidence for a role of TRB3/NIPK as an inhibitor of PKB-mediated insulin signalling in primary hepatocytes
-
Iynedjian PB. Lack of evidence for a role of TRB3/NIPK as an inhibitor of PKB-mediated insulin signalling in primary hepatocytes. Biochem J 2005; 386: 113-8.
-
(2005)
Biochem J
, vol.386
, pp. 113-118
-
-
Iynedjian, P.B.1
-
26
-
-
4544352393
-
Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells
-
Jordan NJ, Gee JM, Barrow D, Wakeling AE, Nicholson RI. Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells. Breast Cancer Res Treat 2004; 87: 167-80.
-
(2004)
Breast Cancer Res Treat
, vol.87
, pp. 167-180
-
-
Jordan, N.J.1
Gee, J.M.2
Barrow, D.3
Wakeling, A.E.4
Nicholson, R.I.5
-
27
-
-
26044443105
-
AKT activation predicts outcome in breast cancer patients treated with tamoxifen
-
Kirkegaard T, Witton CJ, McGlynn LM, et al. AKT activation predicts outcome in breast cancer patients treated with tamoxifen. J Pathol 2005; 207: 139-46.
-
(2005)
J Pathol
, vol.207
, pp. 139-146
-
-
Kirkegaard, T.1
Witton, C.J.2
McGlynn, L.M.3
-
28
-
-
77649268890
-
Inhibitors of the PI3K/Akt/mTOR pathway: New hope for breast cancer patients
-
Ghayad SE, Cohen PA. Inhibitors of the PI3K/Akt/mTOR pathway: new hope for breast cancer patients. Recent Pat Anticancer Drug Discov 2010; 5: 29-57.
-
(2010)
Recent Pat Anticancer Drug Discov
, vol.5
, pp. 29-57
-
-
Ghayad, S.E.1
Cohen, P.A.2
-
29
-
-
0041853713
-
Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activity
-
DeGraffenried LA, Friedrichs WE, Fulcher L, et al. Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activity. Ann Oncol 2003; 14: 1051-6.
-
(2003)
Ann Oncol
, vol.14
, pp. 1051-1056
-
-
DeGraffenried, L.A.1
Friedrichs, W.E.2
Fulcher, L.3
-
31
-
-
44149115749
-
The potential role of Akt phosphorylation in human cancers
-
Cicenas J. The potential role of Akt phosphorylation in human cancers. Int J Biol Markers 2008; 23: 1-9.
-
(2008)
Int J Biol Markers
, vol.23
, pp. 1-9
-
-
Cicenas, J.1
-
32
-
-
18244391514
-
Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients
-
Southeast Sweden Breast Cancer Group
-
Perez-Tenorio G, Stal O; Southeast Sweden Breast Cancer Group. Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients. Br J Cancer 2002; 86: 540-5.
-
(2002)
Br J Cancer
, vol.86
, pp. 540-545
-
-
Perez-Tenorio, G.1
Stal, O.2
-
33
-
-
0038700565
-
Akt kinases in breast cancer and the results of adjuvant therapy
-
Stal O, Perez-Tenorio G, Akerberg L, et al. Akt kinases in breast cancer and the results of adjuvant therapy. Breast Cancer Res 2003; 5: R37-44.
-
(2003)
Breast Cancer Res
, vol.5
-
-
Stal, O.1
Perez-Tenorio, G.2
Akerberg, L.3
-
34
-
-
28844433950
-
Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients
-
Tokunaga E, Kimura Y, Oki E, et al. Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients. Int J Cancer 2006; 118: 284-9.
-
(2006)
Int J Cancer
, vol.118
, pp. 284-289
-
-
Tokunaga, E.1
Kimura, Y.2
Oki, E.3
|